Common polymorphism in promoter of microsomal triglyceride transfer protein gene influences cholesterol, ApoB, and triglyceride levels in young african american men: results from the coronary artery risk development in young adults (CARDIA) study.
暂无分享,去创建一个
S. Juo | L. Colangelo | K. Liu | Z. Han | J. D. Smith | K. Liu
[1] D. Comings,et al. Association of the serotonin transporter gene with serum cholesterol levels and heart disease. , 1999, Molecular genetics and metabolism.
[2] D. Comings,et al. Molecular heterosis as the explanation for the controversy about the effect of the DRD2 gene on dopamine D2 receptor density , 1999, Molecular Psychiatry.
[3] L. Almasy,et al. A genome search identifies major quantitative trait loci on human chromosomes 3 and 4 that influence cholesterol concentrations in small LDL particles. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[4] D. Arveiler,et al. Identification of two polymorphisms in the promoter of the microsomal triglyceride transfer protein (MTP) gene: lack of association with lipoprotein profiles. , 1998, Journal of lipid research.
[5] H. Jamil,et al. An MTP inhibitor that normalizes atherogenic lipoprotein levels in WHHL rabbits. , 1998, Science.
[6] AndersHamsten,et al. A Common Functional Polymorphism in the Promoter Region of the Microsomal Triglyceride Transfer Protein Gene Influences Plasma LDL Levels , 1998 .
[7] R. Krauss,et al. Candidate-gene studies of the atherogenic lipoprotein phenotype: a sib-pair linkage analysis of DZ women twins. , 1998, American journal of human genetics.
[8] D. Gordon. Recent advances in elucidating the role of the microsomal triglyceride transfer protein in apolipoprotein B lipoprotein assembly. , 1997, Current opinion in lipidology.
[9] B Müller-Myhsok,et al. Genetic analysis of complex diseases. , 1997, Science.
[10] E. Nicodème,et al. Microsomal triacylglycerol transfer protein prevents presecretory degradation of apolipoprotein B-100. A dithiothreitol-sensitive protease is involved. , 1996, European journal of biochemistry.
[11] B. Howard,et al. Apolipoprotein E polymorphism in American Indians and its relation to plasma lipoproteins and diabetes. The Strong Heart Study. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[12] J. Moberly,et al. Inhibition of apolipoprotein B and triglyceride secretion in human hepatoma cells (HepG2). , 1996, Journal of lipid research.
[13] L. Pérusse,et al. Apolipoprotein E polymorphism in a French Canadian population of northeastern Quebec: allele frequencies and effects on blood lipid and lipoprotein levels. , 1996, Human biology.
[14] Li-Shin Huang,et al. Demonstration of a Physical Interaction between Microsomal Triglyceride Transfer Protein and Apolipoprotein B during the Assembly of ApoB-containing Lipoproteins (*) , 1996, The Journal of Biological Chemistry.
[15] J. Hokanson,et al. Plasma Triglyceride Level is a Risk Factor for Cardiovascular Disease Independent of High-Density Lipoprotein Cholesterol Level: A Metaanalysis of Population-Based Prospective Studies , 1996, Journal of cardiovascular risk.
[16] M. Muros,et al. Apolipoprotein E polymorphism influence on lipids, apolipoproteins and Lp(a) in a Spanish population underexpressing apo E4. , 1996, Atherosclerosis.
[17] D. Jacobs,et al. Change and secular trends in physical activity patterns in young adults: a seven-year longitudinal follow-up in the Coronary Artery Risk Development in Young Adults Study (CARDIA). , 1996, American journal of epidemiology.
[18] M. Fox,et al. Mutations of the microsomal triglyceride-transfer-protein gene in abetalipoproteinemia. , 1995, American journal of human genetics.
[19] J. Breslow,et al. Genetic basis of lipoprotein disorders. , 1989, Circulation.
[20] D. Rader,et al. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. , 1992, Science.
[21] J. Coresh,et al. Comparison of the plasma levels of apolipoproteins B and A-1, and other risk factors in men and women with premature coronary artery disease. , 1992, The American journal of cardiology.
[22] H. Brewer,et al. Apolipoprotein C‐ll deficiency syndrome due to apo C‐IIHamburg: clinical and biochemical features and Hphl restriction enzyme polymorphism , 1992, European journal of clinical investigation.
[23] D. Jacobs,et al. Meat consumption and its associations with other diet and health factors in young adults: the CARDIA study. , 1991, The American journal of clinical nutrition.
[24] R. Schieken. Effect of Exercise on Lipids a , 1991, Annals of the New York Academy of Sciences.
[25] H. Ginsberg,et al. Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from Hep G2 cells by inhibiting early intracellular degradation of apolipoprotein B. , 1991, The Journal of biological chemistry.
[26] J. Borén,et al. The assembly and secretion of apoB 100 containing lipoproteins in Hep G2 cells. Evidence for different sites for protein synthesis and lipoprotein assembly. , 1990, The Journal of biological chemistry.
[27] K. Howell,et al. Apolipoprotein B is both integrated into and translocated across the endoplasmic reticulum membrane. Evidence for two functionally distinct pools. , 1990, The Journal of biological chemistry.
[28] J. Breslow,et al. Genetic basis of lipoprotein disorders. , 1995, The Journal of clinical investigation.
[29] A. Dyer,et al. Ethnic differences in blood pressure, pulse rate, and related characteristics in young adults. The CARDIA study. , 1989, Hypertension.
[30] J. Scott,et al. The apolipoprotein B gene is constitutively expressed in HepG2 cells: regulation of secretion by oleic acid, albumin, and insulin, and measurement of the mRNA half-life. , 1989, Journal of lipid research.
[31] J. Haddow,et al. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. , 1989, BMJ.
[32] M. Austin. Plasma triglyceride as a risk factor for coronary heart disease. The epidemiologic evidence and beyond. , 1989, American journal of epidemiology.
[33] Charles R.scriver,et al. The Metabolic basis of inherited disease , 1989 .
[34] D. Jacobs,et al. Relationships of low density lipoprotein cholesterol with age and other factors: a cross-sectional analysis of the CARDIA study. , 1988, Annals of clinical research.
[35] K. Namboodiri,et al. Biological and cultural sources of familial resemblance in plasma lipids: A comparison between North America and Israel—the lipid research clinics program , 1988, Genetic epidemiology.
[36] S B Hulley,et al. CARDIA: study design, recruitment, and some characteristics of the examined subjects. , 1988, Journal of clinical epidemiology.
[37] J. Albers,et al. Comparison of commercial kits for apoprotein A-I and apoprotein B with standardized apoprotein A-I and B radioimmunoassays performed at the Northwest Lipid Research Center. , 1988, Journal of lipid research.
[38] S B Hulley,et al. Risk factors for coronary heart disease in adult female twins. Genetic heritability and shared environmental influences. , 1987, American journal of epidemiology.
[39] L. Hunt,et al. Serum apolipoproteins AI and B and lipoproteins in middle aged men with and without previous myocardial infarction. , 1986, British heart journal.
[40] S. Zeger,et al. Longitudinal data analysis using generalized linear models , 1986 .
[41] K Y Liang,et al. Longitudinal data analysis for discrete and continuous outcomes. , 1986, Biometrics.
[42] Warnick Gr. Enzymatic methods for quantification of lipoprotein lipids. , 1986 .
[43] G. Warnick. Enzymatic methods for quantification of lipoprotein lipids. , 1986, Methods in enzymology.
[44] P. Bachorik,et al. Precipitation methods for quantification of lipoproteins. , 1986, Methods in enzymology.
[45] J. Albers,et al. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. , 1982, Clinical chemistry.
[46] W. Raynor,et al. Diet, serum cholesterol, and death from coronary heart disease. The Western Electric study. , 1981, The New England journal of medicine.
[47] R. Bawol,et al. Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease. , 1980, The New England journal of medicine.
[48] D. Jacobs,et al. Scoring systems for evaluating dietary pattern effect on serum cholesterol. , 1979, Preventive medicine.
[49] M. Brown,et al. The LDL receptor locus and the genetics of familial hypercholesterolemia. , 1979, Annual review of genetics.
[50] Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the pooling project. The pooling project research group. , 1978, Journal of chronic diseases.
[51] J. Goldstein,et al. Heterozygous familial hypercholesterolemia: Failure of normal allele to compensate for mutant allele at a regulated genetic locus , 1976, Cell.
[52] W. Hazzard,et al. Immunoassay of human plasma apolipoprotein B. , 1975, Metabolism: clinical and experimental.
[53] R. Levy,et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.
[54] A. Keys,et al. Serum cholesterol response to changes in dietary lipids. , 1966, The American journal of clinical nutrition.
[55] F. Grande,et al. Serum cholesterol response to changes in the diet: I. Iodine value of dietary fat versus 2S-P. , 1965, Metabolism: clinical and experimental.
[56] A. Keys,et al. Serum cholesterol response to changes in the diet: II. The effect of cholesterol in the diet. , 1965, Metabolism: clinical and experimental.